The Global Surgical Lasers Market, by Product (Diode Laser, Dye Laser, Gas Laser, and Solid State Laser), by Application (Cardiology, Dermatology, Dentistry, Gynecology, Ophthalmology, Oncology, Urology, and Others), by Surgery Type (Laparoscopic Surgery, Percutaneous Surgery, and Open Surgery), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 1.4 billion in 2017 and is projected to exhibit a CAGR of 5.4% over the forecast period (2018 - 2026).
Lasers are more precise than conventional surgical tools such as scalpels and therefore, causes less damage to normal tissues. As a result, patients usually experience lesser pain, bleeding, swelling, and scarring. Therefore, it takes less time for patients to heal after laser surgery and they are less likely to get infections. Moreover, the duration of operations with laser therapy is short. The recent past has witnessed increasing utilization of lasers for the treatment of a variety of pathologies due to rising demand for less or minimally invasive treatment modalities. Surgical lasers are widely used in ophthalmology, lithotripsy, the diagnosis and treatment of various cancers, as well as cosmetic and dermatologic procedures.
According to the Royal College of Ophthalmologists 2015 report, in the U.K., over 95% of people who have had refractive surgery are happy with the results. Increasing prevalence of diabetes is a major cause of retinopathy and rising awareness among the population towards solutions for visual impairment, easy procedure of the surgery, increasing government initiatives are some of the factors driving growth of the ophthalmic surgical laser demand. According to World Health Organization (WHO), the number of people with diabetes was estimated to around 422 million in 2014 and is expected to increase in the near future. Manufacturers in the surgical laser market are focused on continuous product innovation, in order to help surgeons across the globe and eventually, increase their market share. For instance, in April 2018, Alcon, the global leader in eye care and a division of Novartis, introduced technological advancements to the LenSx Laser, its market-leading femtosecond laser system. The latest advancements provide new indications for use of the LenSx Laser during cataract and refractive surgeries. In April 2018, Medtronic Plc announced the CE mark and European launch of the Visualase MRI-Guided Laser Ablation System. The Visualase system provides advanced MRI-guided laser ablation technology and can be used in neurosurgery procedures.
Browse 37 Market Data Tables and 25 Figures spread through 160 Pages and in-depth TOC on "Surgical Lasers Market, by Product (Diode Laser, Dye Laser, Gas Laser, and Solid State Laser), by Application (Cardiology, Dermatology, Dentistry, Gynecology, Ophthalmology, Oncology, Urology, and Others), by Surgery Type (Laparoscopic Surgery, Percutaneous Surgery, and Open Surgery), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
To know the latest trends and insights related to surgical lasers market, click the link below:
https://www.coherentmarketinsights.com/market-insight/surgical-lasers-market-2604
Key Takeaways of the Surgical lasers Market:
- The global surgical lasers market is expected to expand at a CAGR of 5.4% during the forecast period (2018–2026), owing to increasing surgical procedures. According to the data from the American Academy of Ophthalmology, in 2017, over 8 million patients in the U.S. alone received laser surgery.
- Major players operating in the global surgical lasers market include Alma Lasers, Abbott Laboratories, Inc., Biolitec AG, BISON MEDICAL Co., Ltd., Boston Scientific Corporation, Cynosure, Inc., Fotona d.o.o., Lumenis, IPG Photonics Corporation, and Spectranetics Corporation
